You are here

Kolltan Pharmaceuticals, Inc.

Kolltan Pharmaceuticals, Inc., is a privately held clinical-stage company focused on the discovery and development of best-in-class drug candidates targeting receptor tyrosine kinases that impact oncology and immunology. Kolltan was founded by Joseph Schlessinger, the Yale School of Medicine Pharmacology Department Chair.